Correction by L-dopa of neurologic manifestations of a chronic portocaval encephalopathy
Girard, P.F.; Trillet, M.; Kopp, N.
Revue Neurologique (Paris) 127(5): 560-563
1972
ISSN/ISBN: 0035-3787 PMID: 4668744 Document Number: 54309
Document emailed within 1 workday
Related Documents
Nechipurenko, N.I.; Dudina, T.V.; Elkina, A.I.; Elkin, I.B. 2000: Pathogenetic basis for the use of GABA-ergic preparations in combination with atropine during chronic pain syndrome in patients with neurologic manifestations of lumbar osteochondrosis Voprosy Meditsinskoi Khimii 46(1): 36-42Zhmurov, V.A.; Oskolkov, S.A.; Kazeko, N.I. 2004: Clinical and biochemical manifestations of chronic pyelonephritis and their correction in population of the northen areas of the Tyumen Territory Terapevticheskii Arkhiv 76(9): 53-57
Weiss, A.; Pitman, E.R.; Javdan, P. 1974: Arousal response in hepatic encephalopathy with L-Dopa American Journal of Gastroenterology 62(6): 497-503
Dieckhöfer, K.; Wolf, R.; Scholl, R. 1977: Tilidine (Valoron R) abuse and delirium in chronic neurologic pain syndromes. A case report from the neurologic-psychiatric viewpoint Münchener Medizinische Wochenschrift 119(44): 1431-1432
Angel, R.W.; Alston, W.; Garland, H. 1971: L-dopa and error correction time in Parkinson's disease Neurology 21(12): 1255-1260
Goulon, M.; Babinet, P.; Raphael, J.C.; Grosbuis, S.; Gajdos, P. 1971: Neurologic manifestations of hyponatremias Revue Neurologique (Paris) 125(3): 219-237
Spitaleri, D.L.; Vitolo, S.; Fasanaro, A.M.; Valiani, R. 1983: Choreoathetosis. Uncommon manifestation during chronic liver disease with portocaval shunt Rivista di Neurologia 53(5): 293-299
Tervaert, J.W.; Kallenberg, C. 1993: Neurologic manifestations of systemic vasculitides Rheumatic Diseases Clinics of North America 19(4): 913-940
Sergnese, G.; Sivieri, R.; Aguggia, M.; Gusmaroli, G. 1991: Neurologic manifestations of lupus erythematosus Minerva Medica 82(5): 259-265
Zeng, Q.Y. 1984: Neurologic manifestations in patients with cryoglobulinemia Zhonghua Nei Ke Za Zhi 23(12): 746-748; 791
Narycheva, I.A.; Ronkin, M.A.; Sokolina, N.A.; Logunova, L.V.; Deliagin, V.M. 1987: Neurologic manifestations of the Marfan syndrome Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(8): 1181-1186
Formel, P.F. 1973: Neurologic manifestations of cardiac disease New York State Journal of Medicine 73(8): 968-971
García-Bragado, F.; Vilardell, M.; Gallart, M.T.; Rodrigo, M.J.; Fonollosa, V.; Bosch, J.; Tornos, J. 1980: Neurologic manifestations in patients with cryoglobulinemia Revista Clinica Espanola 156(5): 329-332
Uldry, P.A.; Steck, A.J.; Regli, F. 1984: Neurologic manifestations of monoclonal gammapathies Schweizerische Medizinische Wochenschrift 114(47): 1678-1685
Millner, M. 1995: Neurologic manifestations of Lyme borreliosis in children Wiener Medizinische Wochenschrift 145(7-8): 178-182
Buchsbaum, H.W.; O'Rourke, R.A.; Schocket, L.I. 1971: Uncommon neurologic manifestations of cardiac disease Arizona Medicine 28(3): 168-172
Bingham, P.M.; Galetta, S.L.; Athreya, B.; Sladky, J. 1995: Neurologic manifestations in children with Lyme disease Pediatrics 96(6): 1053-1056
Alvarez Sabín, J.; Vázquez, J.; Sala, A.; Ortega, A.; Codina Puiggrós, A. 1989: Neurologic manifestations of dissecting aneurysms of the aorta Medicina Clinica 92(12): 447-449
Vernant, J.C.; Smadja, D.; Deforge-Lasseur, C.; Cabre, P.; Buisson, G.; Neisson-Vernant, C.; Desgranges, C. 1994: Vasculitis and neurologic manifestations related to HTLV-1 Presse Medicale 23(31): 1421-1425
Fenelon, G.; Bolgert, F.; Dehen, H. 1986: Neurologic manifestations of the acquired immunodeficiency syndrome Revue Neurologique (Paris) 142(2): 97-106